Skip to main content
    I

    iSpecimen Inc (ISPC)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.60
    -0.05 (-8.17%)

    Market Cap: $1.66M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    iSpecimen Inc (ISPC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to iSpecimen are bioAffinity Technologies (BIAF), XWELL (XWEL) and Exagen (XGN). By market cap, iSpecimen ranks 12th of the 13 companies on this page; Exagen (XGN) is the largest at $105.37M.

    Peer Comparison

    ISPC's revenue growth of -78.7% is below the peer median of -3.5%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    iSpecimen (ISPC)$1.66MN/A1.8x0.0%N/A-78.7%0.00%
    bioAffinity Technologies, Inc. (BIAF)$4.00MN/A0.3x-278.9%-376.1%-26.0%0.00%
    XWELL Inc. (XWEL)$5.62MN/A0.2x-82.9%N/A-7.1%0.00%
    Exagen Inc (XGN)$105.37MN/A1.3x-25.1%-40.4%6.8%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    VivoSim Labs, Inc. (VIVS)$2.58MN/A15.1x0.0%N/A-51.4%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Precipio Inc (PRPO)$39.68MN/A1.3x-4.1%-5.7%8.3%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Peer median$2.78MN/A1.4x0.0%-40.5%-3.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to iSpecimen, ranked by how closely their business, size, sector and industry match. The largest group, 7 of the 12, is in Biotechnology; the other 5 are in Diagnostics & Research.

    CompanyAboutPeers
    bioAffinity Technologies, Inc. (BIAF)Diagnostics & Research
    bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer.
    BIAF competitors
    XWELL Inc. (XWEL)Diagnostics & Research
    XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York.
    XWEL competitors
    Exagen Inc (XGN)Diagnostics & Research
    Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name...
    XGN competitors
    Silexion Therapeutics Corp (SLXN)Biotechnology
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors
    VivoSim Labs, Inc. (VIVS)Biotechnology
    VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
    VIVS competitors
    BioRestorative Therapies Inc (BRTX)Biotechnology
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors
    Precipio Inc (PRPO)Diagnostics & Research
    Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market.
    PRPO competitors
    Revelation Biosciences Inc (REVB)Biotechnology
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Enlivex Therapeutics Ltd (ENLV)Biotechnology
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Calidi Biotherapeutics Inc. (CLDI)Biotechnology
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    Curis Inc (CRIS)Biotechnology
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors

    Frequently Asked Questions About ISPC

    Who are iSpecimen's main competitors?

    The companies most similar to iSpecimen include bioAffinity Technologies (BIAF), XWELL (XWEL), Exagen (XGN), Silexion Therapeutics (SLXN) and VivoSim Labs (VIVS), listed from the closest match.

    Who is iSpecimen's biggest competitor?

    Exagen (XGN) is the largest of the similar companies at $105.37M; bioAffinity Technologies (BIAF) is the closest match by business profile, size, sector and industry.

    How does ISPC stock compare with its competitors?

    ISPC's P/S is 1.8x against a peer median of 1.4x; its net margin is 0.0% against a peer median of 0.0%.

    Which of iSpecimen's competitors pays a higher dividend?

    iSpecimen pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is iSpecimen bigger than its competitors?

    No. iSpecimen is 12th by market cap among the 13 companies on this page; the largest is Exagen (XGN) at $105.37M.